Testosterone for Migraine

by Romeo Mariano, MD on January 16, 2010

Androgenic suppression of spreading depression in familial hemiplegic migraine type 1 mutant mice.

Ann Neurol. 2009 Oct;66(4):564-8

Authors: Eikermann-Haerter K, Baum MJ, Ferrari MD, van den Maagdenberg AM, Moskowitz MA, Ayata C

Familial hemiplegic migraine type 1 (FHM1), a severe migraine with aura variant, is caused by mutations in the CACNA1A gene.

Mutant mice carrying the FHM1 R192Q mutation exhibit increased propensity for cortical spreading depression (CSD), a propagating wave of neuroglial depolarization implicated in migraine aura.

The CSD phenotype is stronger in female R192Q mutants and diminishes after ovariectomy.

Here, we show that orchiectomy reciprocally increases CSD susceptibility in R192Q mutant mice.

Chronic testosterone replacement restores CSD susceptibility by an androgen receptor-dependent mechanism.

Hence, androgens modulate genetically-enhanced CSD susceptibility and may provide a novel prophylactic target for migraine.

Previous post: Role of endogenous testosterone concentration in pediatric stroke.

Next post: Omega-3 Fatty Acids improve macro- and microvascular function in subjects with type 2 diabetes mellitus.